Pharmaceutical & Life Sciences
Cleanroom construction safety, cGMP compliance, hazardous material controls, and OSHA 1910/1926 programs for pharmaceutical, life sciences, and biotechnology facilities.
Pharmaceutical, life sciences, and biotechnology construction — manufacturing facilities, R&D labs, cleanrooms, and clinical processing suites — requires safety expertise that spans OSHA 1926 (construction) and OSHA 1910 (general industry), often simultaneously. A pharmaceutical manufacturing facility under construction is frequently a production facility still running in adjacent areas, with active cGMP controls in place while construction crews work nearby. The interface between those two environments requires careful management.
Cleanroom construction introduces hazards specific to the environment: chemical exposure from cleaning and passivation agents, respiratory hazards from construction activities in controlled environments, and contamination control procedures that go well beyond standard jobsite housekeeping. Hazardous material handling — pharmaceutical manufacturing chemicals, lab reagents, and biotech process gases — adds industrial hygiene requirements that need documented air monitoring programs, exposure assessments, and compound-specific PPE selection.
Greenberg Safety provides EHS consulting for pharmaceutical and life sciences construction projects, including new facility builds, cleanroom expansions, and lab renovations in occupied or partially-occupied facilities. We understand the intersection of OSHA requirements and FDA cGMP expectations, the documentation standards this sector requires from contractors, and the coordination protocols needed when construction and live production share the same building.
Cleanroom Construction Hazards
Construction in or adjacent to cleanrooms generates particles and chemical exposure. Contamination control procedures, HEPA filtration, and negative pressure staging are required to protect both workers and the controlled environment.
Chemical and Biological Exposure
Pharmaceutical and biotech chemicals — solvents, acids, bases, process gases, and biological agents — require documented air monitoring, IDLH assessments, and PPE selection specific to each compound under OSHA 1910.1000.
Energized Systems in Occupied Facilities
Connecting new electrical, HVAC, and process systems to existing infrastructure in an operating facility requires lockout/tagout coordination with plant operations and documented tie-in procedures for every interface.
Containment Area Interfaces
Biotech and life sciences facilities may handle BSL-2 and BSL-3 materials. Construction near containment areas requires specific work permits, air pressure barrier verification, and coordination with the facility biosafety officer.
- OSHA 29 CFR 1910 and 1926
- FDA 21 CFR Parts 210/211 (cGMP)
- USP <797> and <800>
- NIH/CDC Biosafety in Microbiological and Biomedical Laboratories
- ISPE GAMP guidelines
- ANSI/AIHA Z9.2